Gilead challenges US govt patents on HIV drug Truvada

22-08-2019

Gilead challenges US govt patents on HIV drug Truvada

eyesonmilan / Shutterstock.com

Gilead Sciences, the maker of HIV drug Truvada (emtricitabine/tenofovir), has asked the US Patent and Trademark Office (USPTO) to review patents granted to the government covering preventative use of the drug. 


Gilead, PrEP, HIV, Truvada, generics, Teva, CDC, innovation, USPTO, IPRs, inter partest reviews, patents

LSIPR